A deal brokered with the health department guarantees free access but for how long?
Activists fear regulatory delays will come too late for many people who need delamanid and will also stall its release in neighbouring countries.
Patients with drug resistant TB could benefit from a new drug regimen, which will be tested in clinical trials this year.
Two young women are proving to the world that the most deadly strain of TB can be beaten.
Efforts to revamp the international response to the treatment of drug-resistant TB are not proving sufficient.